CAS 128326-82-9

Eberconazole

Description:

Eberconazole is an antifungal agent primarily used in the treatment of dermatological infections caused by various fungi. It belongs to the class of imidazole derivatives and exhibits broad-spectrum antifungal activity. Eberconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting their integrity and function. This mechanism of action makes it effective against a range of dermatophytes and yeast infections. The substance is typically formulated as a topical cream or solution, allowing for localized treatment with minimal systemic absorption. Eberconazole is characterized by its relatively low toxicity and good tolerability in patients, making it a preferred choice for treating superficial fungal infections. Its chemical structure includes a triazole ring, which contributes to its antifungal properties. As with any medication, potential side effects may include local irritation or allergic reactions, but these are generally mild. Overall, Eberconazole is a valuable option in the antifungal therapeutic arsenal, particularly for skin-related fungal conditions.

Formula: C₁₈H₁₄Cl₂N₂

InChI: InChI=1S/C18H14Cl2N2/c19-14-9-13-6-5-12-3-1-2-4-15(12)18(17(13)16(20)10-14)22-8-7-21-11-22/h1-4,7-11,18H,5-6H2

InChI key: InChIKey=MPTJIDOGFUQSQH-UHFFFAOYSA-N

SMILES: ClC1=C2C(C=3C(CCC2=CC(Cl)=C1)=CC=CC3)N4C=CN=C4

Synonyms:

• 1-(2,4-Dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-1H-imidazole
• 1H-Imidazole, 1-(2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-
• Eberconazole

Eberconazole

CAS: 128326-82-9

Eberconazole, a potent antifungal, is an imidazole derivative effective against dermatophytes. Administered topically.

Formula: C₁₈H₁₄Cl₂N₂

Color and Shape: Solid

Molecular weight: 329.22

Ref: TM-T72915

Eberconazole

Controlled Product

CAS: 128326-82-9

Formula: C₁₈H₁₄Cl₂N₂

Color and Shape: Neat

Molecular weight: 329.223

Ref: TR-E128320

Eberconazole

CAS: 128326-82-9

Eberconazole is an analog of a protein kinase inhibitor that has been shown to have anticancer properties. It is used in the treatment of various types of cancer and tumors in humans. Eberconazole works by inhibiting cyclin-dependent kinases, which are enzymes involved in cell division and growth. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. Eberconazole has been found to be effective against Chinese hamster ovary (CHO) cells and has shown promise as a potential anticancer drug. It is excreted primarily through urine after administration.

Formula: C₁₈H₁₄Cl₂N₂

Purity: Min. 95%

Molecular weight: 329.2 g/mol

Ref: 3D-DFA32682